ACCENDRA HEALTH INC/VA/
ACHNYSEIndustrials · Wholesale-Medical, Dental & Hospital Equipment & Supplies · VA · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.76B | $10.70B | $10.33B | $9.96B | $9.79B | $8.48B |
| Operating income | $27.5M | −$207.8M | $104.5M | $142.9M | $368.5M | $204.1M |
| Net income | −$1.10B | −$362.7M | −$41.3M | $22.4M | $221.6M | $29.9M |
| Total assets | $2.45B | $4.66B | $5.09B | $5.39B | $3.54B | $3.34B |
| Total liabilities | $2.91B | $4.09B | $4.17B | $4.44B | $2.60B | $2.62B |
| Equity | −$461.0M | $565.2M | $924.2M | $945.6M | $938.5M | $712.1M |
| EPS (diluted) | $-14.31 | $-4.73 | $-0.54 | $0.29 | $2.94 | $0.47 |
| Shares out. | 77.2M | 76.6M | 76.3M | 75.6M | 73.5M | 62.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 1.0%
- Net margin
- −39.8%
- Return on equity
- 238.8%
- Return on assets
- −44.9%
- Return on capital (ROCE)
- 1.8%
- Liabilities / assets
- 118.8%
- Debt / equity
- —
- Book value / share
- $-5.97
- Revenue growth (YoY)
- −74.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.59distress
- Accruals / assets
- −40.7%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Operating margin is positive
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 4, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Charles Schwab Investment Management IncPassive (13G)May 14, 2026
- Webb Kevin MichaelPassive (13G)Mar 30, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Coliseum Capital Management, LlcActivist (13D)Nov 14, 2025
- Dimensional Fund Advisors LpPassive (13G)Oct 9, 2025
- Blackrock, Inc.Passive (13G)Oct 2, 2025
- Flynn James EPassive (13G)May 13, 2025
- Fmr LlcPassive (13G)May 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Galloway Heath HOfficer — EVP,General Counsel & CorpSecy | May 18, 2026 | Tax withholding | 1,822 | $2.91 |
| Leon Jonathan AOfficer — EVP & CFO | May 15, 2026 | Tax withholding | 1,770 | $3.04 |
| Pesicka Edward AOfficer — President & CEO | May 15, 2026 | Tax withholding | 17,692 | $3.04 |
| Galloway Heath HOfficer — EVP,General Counsel & CorpSecy | May 15, 2026 | Tax withholding | 966 | $3.04 |
| Bernocchi Perry AOfficer — EVP, Chief Operating Officer | May 15, 2026 | Tax withholding | 7,908 | $3.04 |
| Kline Teresa L.Director | May 14, 2026 | Grant | 31,191 | $0.00 |
| Klemash Stephen WDirector | May 14, 2026 | Grant | 31,191 | $0.00 |
| Gardner-Smith KennethDirector | May 14, 2026 | Grant | 31,191 | $0.00 |
| Beck Mark ADirector | May 14, 2026 | Grant | 31,191 | $0.00 |
| Pesicka Edward AOfficer — President & CEO | Mar 20, 2026 | Tax withholding | 58,945 | $2.03 |
| Leon Jonathan AOfficer — EVP & CFO | Mar 20, 2026 | Tax withholding | 11,286 | $2.03 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 5.8M | 5.2 | -1.7% |
| Apr 30, 2026 | 5.9M | 8.3 | -13.2% |
| Apr 15, 2026 | 6.9M | 9.5 | -9.0% |
| Mar 31, 2026 | 7.5M | 8.0 | -8.0% |
| Mar 13, 2026 | 8.2M | 11.1 | +0.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 22, 2026
- Director / officer change · Shareholder voteMay 15, 2026
- Entered a material agreement · Regulation FD disclosureMay 11, 2026
- Results of operations · Regulation FD disclosureMay 11, 2026
- Results of operations · Regulation FD disclosureFeb 19, 2026
- Entered a material agreement · Completed an acquisition or disposition · New financial obligation · Director / officer change · Amended charter or bylaws · Regulation FD disclosureDec 31, 2025
- Director / officer change · Regulation FD disclosureDec 18, 2025
- Director / officer change · Regulation FD disclosureDec 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDMay 29, 2026
- 8-KMay 22, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 20, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 19, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 19, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 19, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 19, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 18, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 18, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 18, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 18, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 18, 2026
- S-8May 15, 2026
- 8-KMay 15, 2026
- SCHEDULE 13G/AMay 14, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.